Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Name: Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy
Published: 2019
License: Public Domain

Consorzio Oncotech · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

metastatic breast cancer, locally advanced breast cancer, hormone receptor positive, human epidermal growth factor receptor type 2 negative, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Related documents